The Supreme Court refused to interfere with the Centre’s decision to de-control prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation. “You approach Centre seeking modification in the order. If the Centre does not do anything then you can come back,” a bench comprising Chief Justice HL Dattu and justices MB Lokur and AK Sikri said. The PIL had alleged that hike in prices of life saving drugs is against public interest and would lead to windfall gain to the pharmaceutical companies at the cost of endangering lives of million of Indians.
The information in this private circulation is not legal advice and should not be treated as such. The information is taken from public domain and is purely for private and non- commercial purposes. We do not represent that the information is correct, accurate, complete or non- misleading.
This disclaimer will be governed by and construed in accordance with laws of India, and any disputes relating to this disclaimer will be subject to the exclusive jurisdiction of the courts of the Republic of India.